Background: Current guidelines recommend non-invasive testing and treatment of young dyspeptic patients without alarming symptoms. Aim: to evaluate the accuracy of a new rapid immunochromatographic stool test to diagnose Helicobacter pylori infection before and after treatment compared to a gold standard. Methods: Prospective, single blind study, performed in a tertiary care hospital. 303 consecutive dyspeptic patients underwent endoscopy with multiple biopsies. Infected patients were offered a treatment and invited to come back 4-6 weeks after the end of therapy to repeat the endoscopy. Patients were also asked to provide a stool sample before and after therapy. Results: 149 patients were H pylori infected. The sensitivity and specificity before treatment were 91.3% and 93.5%; after treatment 92% and 100%. The Likelihood Ratios (LRs) were robust enough to produce significant changes from pre-test to post-test probability both in pre treatment (LR +ve=14, LR-ve= 0.093) and post treatment (LR +ve= 19.6, LR-ve= 0.095). Conclusions: The novel immunochromatographic stool test is fast, easy to perform and provides good differentiation between positive and negative results. It might become a rapid near patients test easily performed in the physician office.
Gatta L, Perna F, Ricci C, Osborn JF, Tampieri A, Bernabucci V, et al. (2004). A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 20(4), 469-474 [10.1111/j.1365-2036.2004.02094.x].
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment
GATTA, LUIGI;PERNA, FEDERICO;RICCI, CHIARA;TAMPIERI, ANDREA;BERNABUCCI, VERONICA;MIGLIOLI, MARIO;VAIRA, BERARDINO
2004
Abstract
Background: Current guidelines recommend non-invasive testing and treatment of young dyspeptic patients without alarming symptoms. Aim: to evaluate the accuracy of a new rapid immunochromatographic stool test to diagnose Helicobacter pylori infection before and after treatment compared to a gold standard. Methods: Prospective, single blind study, performed in a tertiary care hospital. 303 consecutive dyspeptic patients underwent endoscopy with multiple biopsies. Infected patients were offered a treatment and invited to come back 4-6 weeks after the end of therapy to repeat the endoscopy. Patients were also asked to provide a stool sample before and after therapy. Results: 149 patients were H pylori infected. The sensitivity and specificity before treatment were 91.3% and 93.5%; after treatment 92% and 100%. The Likelihood Ratios (LRs) were robust enough to produce significant changes from pre-test to post-test probability both in pre treatment (LR +ve=14, LR-ve= 0.093) and post treatment (LR +ve= 19.6, LR-ve= 0.095). Conclusions: The novel immunochromatographic stool test is fast, easy to perform and provides good differentiation between positive and negative results. It might become a rapid near patients test easily performed in the physician office.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.